Dermatology Times, July 2018 (Vol. 39, No. 07)

Pricing patients out of healthcare?

July 23, 2018

Patients are being victimized by the high cost of drug therapy. "We can help them by prescribing less expensive drugs and by guiding them to the least expensive places to purchase them," says Dr. Norman Levine.

Four questions every provider should ask about digital technology

June 26, 2018

There are four questions physicians should ask when considering using digital healthcare technologies, says Michael L. Hodgkins, M.D., chief medical officer for the American Medical Association. View the slideshow for more information.

Combination therapy improves survival in melanoma

June 11, 2018

The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.

Immunotherapy still works post treatment in melanoma

June 11, 2018

Pembrolizumab has antitumor activity that is durable long after treatment is stopped in patients with advanced melanoma, researchers reported at the 2018 annual meeting of the American Society of Clinical Oncology (ASCO) on June 4.

The atopic march strides toward eosinophilic esophagitis

March 19, 2018

Eczema, food allergy, and asthma independently and cumulatively increase the risk for eosinophilic esophagitis (EoE), according to findings presented at the 2018 American Academy of Allergy, Asthma & Immunology and World Allergy Organization Joint Congress in Orlando.

Revised melanoma staging criteria

November 04, 2017

Staging system is derived from a new dataset of patients from 10 cancer centers around the world. Dermatologists should consider AJCC tumor characteristics as well as other factors in risk assessment, counseling, and follow-up plans for patients. Update takes effect in January 2018.